BCR-ABL QUANTITATIVE, MRD MONITOR
BCR-ABL is a fusion gene formed by the rearrangement of breakpoint cluster region (BCR) on chromosome 22 with the ABL protooncogene on chromosome 9 leading to the formation of Philadelphia chromosome. This rearrangement is seen in almost 95% patients with CML. The Quantitative assay helps in the management of the disease and monitors effect of therapy.
Parameter(s) covered : 1
Report Frequency: Sample Mon through Sat by 10 am; Report Next working day
Special Instruction: Physician prescription is mandatory.
Price : ₹ 6500.00
Parameters
- BCR-ABL QUANTITATIVE, MRD MONITOR